Q1: 2026-05-06 Earnings Summary
EPS of -$1.38 beats by $2.76
|
Revenue of
$311.34M
(126.84% Y/Y)
beats by $10.42M
Madrigal Pharmaceuticals, Inc. (MDGL) Q1 2026 Earnings Call May 6, 2026 8:00 AM EDT
Company Participants
Tina Ventura - Chief Investor Relations Officer
William Sibold - CEO, President & Director
David Soergel - Executive VP & Chief Medical Officer
Mardi Dier - Executive VP & CFO
Conference Call Participants
Prakhar Agrawal - Cantor Fitzgerald & Co., Research Division
Ashwani Verma - UBS Investment Bank, Research Division
Srikripa Devarakonda - Truist Securities, Inc., Research Division
Ritu Baral - TD Cowen, Research Division
Yasmeen Rahimi - Piper Sandler & Co., Research Division
Eliana Merle - Barclays Bank PLC, Research Division
Thomas Smith - Leerink Partners LLC, Research Division
Michael DiFiore - Evercore ISI Institutional Equities, Research Division
Jonathan Wolleben - Citizens JMP Securities, LLC, Research Division
William Wood - B. Riley Securities, Inc., Research Division
Presentation
Operator
Good morning, and thank you for standing by. Welcome to Madrigal Pharmaceuticals First Quarter 2026 Earnings Conference Call. [Operator Instructions] As a reminder, today's conference call is being recorded. I would now like to introduce Ms. Tina Ventura, Chief Investor Relations Officer. Please go ahead.
Tina Ventura
Chief Investor Relations Officer
Thanks, Brilla. Good morning, everyone, and thank you for joining us to discuss Madrigal's First Quarter 2026 earnings. We issued a press release this morning and put the slide deck to accompany this webcast on the Investor Relations section of our website. On the call with me today is Bill Sibold, Chief Executive Officer; Dave Soergel, Chief Medical Officer; and Mardi Dier, Chief Financial Officer. They will provide prepared remarks followed by Q&A.
Please note on Slide 2. We will be making certain forward-looking statements today. We refer you to our SEC filings for a discussion of the risks that may cause actual results to differ from the forward-looking statements. With that, I will now turn the call over to Bill on Slide 3.
此内容由惯性聚合(RSS阅读器)自动聚合整理，仅供阅读参考。 原文来自 — 版权归原作者所有。